Back
John Hancock Financial Opportunities Fund Vs. Halozyme Therapeutics Industry Stock Comparison
Buy
81
BTO
John Hancock Financial Opportunities Fund
Last Price:
$34.52
Seasonality Move:
3.24%
Buy
63
HALO
Halozyme Therapeutics
Last Price:
$53.99
Seasonality Move:
2.59%
Buy
81
John Hancock Financial Opportunities Fund (BTO)
is a Buy
Is John Hancock Financial Opportunities Fund a Buy, Sell or Hold?
-
The current John Hancock Financial Opportunities Fund [BTO] share price is $34.69. The Score for BTO is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
-
BTO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
63
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy, Sell or Hold?
-
The current Halozyme Therapeutics [HALO] share price is $53.45. The Score for HALO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BTO Stock Price Chart
What is John Hancock Financial Opportunities Fund's stock price today?
-
The John Hancock Financial Opportunities Fund share price today is $34.69The current trend is moderately bullish and BTO is experiencing selling pressure, which indicates risk of future bearish movement.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $53.45Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing slight buying pressure.
BTO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.79 | Buy |
Relative Strength Index (14 RSI): | 65.73 | Buy |
Chaikin Money Flow: | -47788 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.07 - 34.23) | Buy |
Bollinger Bands (100): | (31.92 - 36.7) | Buy |
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.16 | Sell |
Relative Strength Index (14 RSI): | 42.23 | Sell |
Chaikin Money Flow: | 269856 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.43 - 64.39) | Sell |
Bollinger Bands (100): | (52.72 - 62.78) | Sell |
BTO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.55 | Buy |
20-day SMA: | 33.23 | Buy |
50-day SMA: | 32.47 | Buy |
200-day SMA: | 34.29 | Buy |
8-day EMA: | 34.42 | Buy |
20-day EMA: | 33.49 | Buy |
50-day EMA: | 33.23 | Buy |
200-day EMA: | 33.45 | Buy |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.79 | Sell |
20-day SMA: | 58.92 | Sell |
50-day SMA: | 60.52 | Sell |
200-day SMA: | 56.33 | Sell |
8-day EMA: | 54.59 | Sell |
20-day EMA: | 57.49 | Sell |
50-day EMA: | 58.81 | Sell |
200-day EMA: | 55.36 | Sell |
John Hancock Financial Opportunities Fund Earnings Growth & BTO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.
John Hancock Financial Opportunities Fund Technical Analysis
May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Halozyme Therapeutics Technical Analysis
May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |